Who
Timothy J. Scannell
Director
Company insider
Files Form 4 as: Director, Masimo; Director, NovoCure; Director, Insulet; Director, Exact Sciences; Director, AeroClean Technologies; President and COO, Stryker.
In numbers
- Trades disclosed
- 205
- Buys
- 1
- Sells
- 25
- Bought
- $95K
- Sold
- $20.7M
- Companies
- 6
- Companies where not an officer
- 5
- First trade
- 10 Feb 2009
- Last trade
- 10 Jun 2026
- Last filed
- 12 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 10 Jun 2026filed 12 Jun 2026 | MasimoMedical Devices | SEC FORM 4 Code D | $469K2,608 at $180.00 | filing |
| 10 Jun 2026filed 12 Jun 2026 | Masimooption or derivative · Medical Devices | SEC FORM 4 Code D | —1,119 | filing |
| 10 Jun 2026filed 12 Jun 2026 | Masimooption or derivative | SEC FORM 4 Code D | —1,119 | filing |
| 10 Jun 2026filed 12 Jun 2026 | Masimo | SEC FORM 4 Code D | $469K2,608 at $180.00 | filing |
| 3 Jun 2026filed 5 Jun 2026 | NVCR NovoCureMedical Devices | SEC FORM 4 Code A | —11,610 at $0.00 | filing |
| 3 Jun 2026filed 5 Jun 2026 | NVCR NovoCureoption or derivative · Medical Devices | SEC FORM 4 Code A | —16,999 at $0.00 | filing |
| 3 Jun 2026filed 5 Jun 2026 | NVCR NovoCureoption or derivative · Medical Devices | SEC FORM 4 Code A | —16,999 at $0.00 | filing |
| 3 Jun 2026filed 5 Jun 2026 | NVCR NovoCureMedical Devices | SEC FORM 4 Code A | —11,610 at $0.00 | filing |
| 2 Jun 2026filed 3 Jun 2026 | NVCR NovoCureMedical Devices | SEC FORM 4 Sold | $46K2,945 at $15.77 | filing |
| 2 Jun 2026filed 3 Jun 2026 | NVCR NovoCureMedical Devices | SEC FORM 4 Sold | $46K2,945 at $15.77 | filing |
| 20 May 2026filed 21 May 2026 | PODD InsuletMedical Devices | SEC FORM 4 Code A | —1,660 at $0.00 | filing |
| 20 May 2026filed 21 May 2026 | PODD InsuletMedical Devices | SEC FORM 4 Code A | —1,660 at $0.00 | filing |
| 29 Apr 2026filed 5 May 2026 | MasimoMedical Devices | SEC FORM 4 Code M | —1,225 at $0.00 | filing |
| 29 Apr 2026filed 5 May 2026 | Masimooption or derivative · Medical Devices | SEC FORM 4 Code M | —1,225 at $0.00 | filing |
| 29 Apr 2026filed 5 May 2026 | Masimooption or derivative | SEC FORM 4 Code M | —1,225 at $0.00 | filing |
| 29 Apr 2026filed 5 May 2026 | Masimo | SEC FORM 4 Code M | —1,225 at $0.00 | filing |
| 23 Apr 2026filed 5 May 2026 | Masimooption or derivative · Medical Devices | SEC FORM 4 Code A | $200K1,119 at $178.71 | filing |
| 23 Apr 2026filed 5 May 2026 | Masimooption or derivative | SEC FORM 4 Code A | $200K1,119 at $178.71 | filing |
| 4 Jun 2025filed 6 Jun 2025 | NVCR NovoCureoption or derivative · Medical Devices | SEC FORM 4 Code A | —16,697 at $0.00 | filing |
| 4 Jun 2025filed 6 Jun 2025 | NVCR NovoCureMedical Devices | SEC FORM 4 Code A | —11,215 at $0.00 | filing |
News
Reviewing NeurAxis (NASDAQ:NRXS) & NovoCure (NASDAQ:NVCR)NVCR · tickerreport.com · 15 Oct 2026NovoCure (NASDAQ:NVCR) and Medline (NASDAQ:MDLN) Financial AnalysisNVCR · themarketsdaily.com · 8 Oct 2026NovoCure (NASDAQ:NVCR) versus Kewaunee Scientific (NASDAQ:KEQU) Head-To-Head ReviewNVCR · dailypolitical.com · 7 Oct 2026
0 headlines in the last 90 days name Timothy J. Scannell; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.